Predictive Oncology Market Outlook
| POAIDelisted Stock | USD 5.95 0.00 0.00% |
Under 55% of Predictive Oncology's investor base is interested to short. The analysis of current outlook of investing in Predictive Oncology suggests that many traders are impartial regarding Predictive Oncology's prospects. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Comfort Level 45
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Predictive Oncology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Predictive Oncology.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Predictive Oncology is 'Not Rated'. The recommendation algorithm takes into account all of Predictive Oncology's available fundamental, technical, and predictive indicators you will find on this site.
Execute Predictive Oncology Advice
The Predictive recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Predictive Oncology. Macroaxis does not own or have any residual interests in Predictive Oncology or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Predictive Oncology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
For the selected time horizon Predictive Oncology has a Risk Adjusted Performance of (0.05), Jensen Alpha of (0.70), Total Risk Alpha of (1.39) and Treynor Ratio of 0.2962We provide trade recommendations to complement the recent expert consensus on Predictive Oncology. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Predictive Oncology is not overpriced, please check all Predictive Oncology fundamentals, including its cash per share, target price, and the relationship between the gross profit and book value per share . Given that Predictive Oncology has a number of shares shorted of 68.79 K, we recommend you to check out Predictive Oncology market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.
Predictive Oncology Trading Alerts and Improvement Suggestions
| Predictive Oncology is now traded under the symbol AGPU. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Predictive Oncology is not yet fully synchronised with the market data | |
| Predictive Oncology had very high historical volatility over the last 90 days | |
| Predictive Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.62 M. Net Loss for the year was (10.86 M) with profit before overhead, payroll, taxes, and interest of 814.04 K. | |
| Predictive Oncology currently holds about 25.39 M in cash with (11.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. |
Predictive Oncology Returns Distribution Density
The distribution of Predictive Oncology's historical returns is an attempt to chart the uncertainty of Predictive Oncology's future price movements. The chart of the probability distribution of Predictive Oncology daily returns describes the distribution of returns around its average expected value. We use Predictive Oncology price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Predictive Oncology returns is essential to provide solid investment analysis for Predictive Oncology.
| Mean Return | -0.81 | Value At Risk | -19.12 | Potential Upside | 15.02 | Standard Deviation | 10.53 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Predictive Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 2373 shares by Raymond Vennare of Predictive Oncology at 5.9 subject to Rule 16b-3 [view details]
Predictive Oncology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Predictive . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.1 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 5.7 | |||
| Day Typical Price | 5.78 | |||
| Market Facilitation Index | 0.6 | |||
| Price Action Indicator | 0.25 |
About Predictive Oncology Buy or Sell Advice
When is the right time to buy or sell Predictive Oncology? Buying financial instruments such as Predictive Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Predictive Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Predictive Stock
If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |